Active ingredients: calcitriol
What it is used for
For the management of established post-menopausal osteoporosis by increasing calcium absorption, elevating circulating levels of calcitriol, and reducing vertebral fracture frequency. For the prevention of corticosteriod-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. For the treatment of hypoclacamia in patients with uraemic osteodystrophy, hypoparathyroidism and Vitamin D resistant rickets. INDICATIONS AS AT 4 MARCH 2004: Rocaltrol is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of a traumatic fracture. Rocaltrol is also indicated for the prevention of corticosteriod-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. Rocaltrol is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphatemic rickets.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Protect from Light
- Protect from Moisture
- Lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
OVAL SOFT GELATIN CAPSULES, ONE HALF BROWN-ORANGE TO RED-ORANGE, OPAQUE, ONE HALF WHITE TO GREY-YELLOW OR ORANGE-GREY, OPAQUE.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient calcitriol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)